ELTX 10 Year Annualized Return and Average Annual Return

ELTX Average Annual Return Chart Since 2021
Growth of $10,000.00
Without Dividends Reinvested Into ELTX

Also see:
• ELTX stock yearly return 2021
• ELTX stock yearly return 2022
• ELTX stock yearly return 2023
• ELTX stock yearly return 2024
• ELTX stock yearly return 2025
• ELTX YTD return
Average Annual Return Benchmarks
Compare ELTX average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
ELTX Share Performance
ELTX Average Annual Return Table Since 2021
Start date: 02/08/2021
End date: 05/15/2026
Start price/share: $182.50
End price/share: $10.63
Dividends collected/share: $0.00
Total return: -94.18%
ELTX Average Annual Return: -41.74%
Starting investment: $10,000.00
Ending investment: $582.29
Years: 5.26


ELTX average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Elicio Therapeutics Inc
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company. Co. is engaged in developing a pipeline of immunotherapies for the treatment of cancer. Co. provides a platform, amphiphile (AMP) that delivers immuno therapeutics directly to the lymph nodes (brain center) of the immune system. Co.'s lead product candidate, ELI-002, is being developed to treat cancers driven by kirsten rat sarcoma (KRAS). It is conducting a Phase I/II clinical trial of ELI-002 (AMPLIFY-201). The ELTX average annual return since 2021 is shown above.

The Average Annual Return on the ELTX average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether ELTX average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the ELTX average annual return calculation with any dividends reinvested as applicable (on ex-dates).
ELTX Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree ELTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
Elicio Therapeutics (ELTX) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

ELUT Average Annual Return
ELVN Average Annual Return
EMBC Average Annual Return
ENOV Average Annual Return
ENSC Average Annual Return
ENSG Average Annual Return
ENTA Average Annual Return
ENVB Average Annual Return
EOLS Average Annual Return
EQ Average Annual Return
More Healthcare companies »
 

ELTX 10 Year Annualized Return & Average Annual Return | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.